HeartFlow’s shares fell 19.1% after earnings, despite raised full-year revenue and gross-margin guidance. The transcript does not identify a specific disappointment; management’s outlook was raised, so the selloff cannot be attributed to a guidance cut or a stated slowdown based on the available information.
- Q3 revenue was $72.9 million, up 57% year over year; U.S. revenue increased 60%.
- Management raised full-year revenue guidance to $262 million–$264 million, or 49%–50% year-over-year growth, and Plaque revenue guidance to $36 million–$37 million.
- Non-GAAP gross-margin guidance increased to approximately 82.5%; the company reiterated its midterm target of 85%.
- HeartFlow expects approximately 1,300 Plaque-activated accounts by year-end, with Plaque coverage reaching about 82% of U.S. lives.
- The company expects 2026 new account activations to exceed the 340 added in 2025.
Community Discussion